| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $461.1M | +97.9% |
| R&D Expense | $28.9M | +51.4% |
| SG&A Expense | $132.4M | +24.8% |
| Operating Income | -$286.6M | -10.3% |
| Pre-tax Income | -$165.2M | +43.8% |
| Income Tax | $533K | +120.2% |
| Net Income | -$165.7M | +43.7% |
| EPS (Basic) | -$0.80 | +97.8% |
| EPS (Diluted) | -$0.80 | +97.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $246.6M | +253.7% |
| Accounts Receivable | $5.6M | +21.0% |
| Current Assets | $312.9M | +216.2% |
| Total Assets | $1.57B | +959.8% |
| Current Liabilities | $250.6M | -4.9% |
| Long-term Debt | $172.9M | +625.1% |
| Total Liabilities | $1.59B | +362.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$149.0M | +16.9% |
| Capital Expenditures | $28.2M | +74.5% |
| Investing Cash Flow | -$31.0M | -43.6% |
| Financing Cash Flow | $400.6M | +169.6% |
| Free Cash Flow | -$177.2M | +9.4% |
| Stockholders' Equity |
| -$19.9M |
| +97.4% |